Can Microbiome Science Bring about a Sea Change in Medical Care?
A growing number of experts envision fundamental changes in the way doctors diagnose and treat disease, potentially ushering in a new era of sustainability in healthcare.
The World Asthma Foundation introduces the Microbiome First - Pathway to Sustainable Healthcare initiative and invites healthcare professionals, non-communicable disease community leaders, and stakeholders to participate in the inaugural Microbiome First Summit, a pathway to sustainable healthcare.
Summit Details:
The goal of sustainable healthcare is to improve quality of life at reduced cost by addressing the microbiome first, as recent research shows that all of these non-communicable diseases have a relationship to the microbiome.
The three-day virtual summit, May 17-19, 2022, brings together thought leaders to present Microbiome First strategies, beyond the soundbites and buzzwords, that is designed to provide thoughtful and meaningful discussions.
Noncommunicable diseases and conditions or NCDs are the number 1 world-wide cause of death. Most of the more than 150 chronic disorders fall into three major categories (allergic, autoimmune or inflammatory). They are also known by the systems they affect:
Systemic NCDs also exist (e.g., lupus and frailty). Both the risk of and persistence of NCDs are significantly influenced by the human microbiome.
The Microbiome First - Pathway to Sustainable Healthcare is a suggested 21st century healthcare paradigm that prioritizes the entire human, the human superorganism, beginning with the microbiome.
What You'll Learn:
The Microbiome First - Pathway to Sustainable Healthcare summit panel discussion aims to kickstart a 21st century healthcare paradigm that prioritizes:
Focus on the human microbiome that could facilitate the move toward sustainable healthcare
How certain keystone bacteria and critical windows of development show that changes in even a few microbiota-prioritized medical decisions could make a significant difference in health across the life course
Everyone is invited and it's free to participate. Microbiome First - Pathway to Sustainable Healthcare Virtual Summit taking place May 17-19, 2022.
Keynote
The cost of Healthcare increases each year, but overall health of the general population does not improve. Non-communicable diseases kill millions of people but there are very few cures. This summit aims to change the way NCDs are managed.
Rodney Dietert, PhD
"Big Picture View of Our Tiny Microbes"
Cornell University Professor Emeritus Ithaca, NY, USA Author of The Human Superorganism.
The cost of Healthcare increases each year, but overall health of the general population does not improve. Non-communicable diseases kill millions of people but there are very few cures. This summit aims to change the way NCDs are managed.
World Asthma Foundation
"Impact and burden of NCDs"
WAF’s mission is to empower the World Asthma community through education, collaboration, and advocacy.
"Brain-Gut-Microbiome System: Pathways and Implications for Autism Spectrum Disorder"
Expert on the brain’s role in creativity, language and empathy. Associate Professor in the USC Chan Division of Occupational Science and Occupational Therapy. Los Angeles, CA, USA
"Dietary Resistant Starch Effects on Gut Pathobiont Translocation and Systemic Autoimmunity"
Chief of Rheumatology and Clinical Immunology at University Hospital of Münster. GERMANY Adjunct Associate Professor in Immunobiology at Yale School of Medicine.
"Gut-microbiota-targeted diets modulate human immune status"
Senior research scientist and Associate Professor in the Department of Microbiology and Immunology at the Stanford University School of Medicine. Palo Alto, CA, USA
"Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation"
Associate Professor, Principal Research Fellow The University of Queensland Diamantina Institute Faculty of Medicine The University of Queensland Translational Research Institute. Woolloongabba, QLD, AUSTRALIA
"Protecting the gut microbiota from antibiotics with engineered live biotherapeutics"
Scientist, Wyss Institute of Harvard University and Institute of Medical Engineering and Science of Massachusetts Institute of Technology (MIT) Boston, MA, USA
"The Gut–Brain Axis and the Microbiome: Mechanisms and Clinical Implications"
Gastroenterologist, Neuroscientist, Distinguished Research Professor Department of Medicine, UCLA David Geffen School of Medicine Executive Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience at UCLA Founding Director, UCLA Brain Gut Microbiome Center. Los Angeles, CA, USA
"House dust mite shedding in human milk: a neglected cause of allergy susceptibility"
Clinical and translational researcher Research Fellow, The University of Western Australia Honorary Research Associate, Telethon Kids Institute. Perth, WA, AUSTRALIA
Contact us to participate and help make healthcare sustainable while improving health outcomes.
GROW YOUR GLOBAL NETWORK
Unlock opportunities for 2021 and beyond. With two days crossing paths with senior leadership from potential partners and customers, the Forum is a place to build relationships, share your knowledge, and keep the discussion going long after the weekend is over.